Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
JLABS
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JLABS Press Releases
JNJ Press releases
(-) Other news
Partner news
Press release

Period

2019

Jan
Mar
Apr
Jun
Jul
Aug
Oct

Locations & regions

EMEA

Focus area

Pharmaceuticals

Clear filters

News

Cyprio Wins Women Startup Challenge Europe HealthTech

Read full story

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

Read full story

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

Read full story

binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health

Read full story

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story

Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38

Read full story

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

Read full story

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Read full story

Sidebar

Currently trending

Currently trending

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools
At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience
The science of prevention
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute

Trending

Trending

Johnson & Johnson Innovation, Change One Thing, Change Everything: Medopad

Johnson & Johnson Innovation, Change One Thing, Change Everything: Exonate

Change 1 Thing, Change Everything: Improving Contact Lenses